NIH Research to Address the Real-Life Challenges of Opioid Crisis

May 13, 2022
1 min read

Updated: Jun 16, 2022

Atlanta, GA | May 2022

https://directorsblog.nih.gov/2022/05/10/rx-and-illicit-drug-summit-a-conversation-on-helping-people-and-families-in-need/

Recent Posts

See All

FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from Fentanyl

Cambridge, MA | May 2026 PRNewswire/ -- Clear Scientific Inc., a clinical stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted its lead asset,

Clear Scientific Presents at the Inaugural UC Summit on Methamphetamine: Advancing Research, Policy, and Public Health.

Cambridge, MA | April 2026 On April 17, 2026, Piercen Oliver PhD, VP of Research & Development of Clear Scientific Inc. presented at the Inaugural UC Summit on Methamphetamine: Advancing Research, Po

NIDA Director, Nora Volkow talks about the need for treatments for stimulant and polysubstance use and overdoses during the 152 Meeting of the National Advisory Council on Drug Abuse

Cambridge, MA | March 2026 https://videocast.nih.gov/watch/73b8cb15-0e86-11f1-9f14-124f0a52e769 During the 152 meeting of the National Advisory Council on Drug Abuse, NIDA Director, Nora Volkow, dis

NIH Research to Address the Real-Life Challenges of Opioid Crisis

Recent Posts

Comments

Contact Us